Contact
searchSearch
HMP Global

Optimizing Therapeutic Selection for Common Comorbidities and Special Patient Populations with Psoriasis: A Case-Based Approach

06/02/2017

Popular Articles

Alan Bonder
Q&As
Alan Bonder, MD, on Extrahepatic Autoimmune Diseases in Patients With Primary Biliary Cholangitis
10/21/2020
About 25% of patients with one autoimmune disease are likely to develop another autoimmune condition. Dr Bonder, from Beth Israel Deaconess Medical Center in Boston, talks about the importance of screening patients with primary biliary...
About 25% of patients with one autoimmune disease are likely to develop another autoimmune condition. Dr Bonder, from Beth Israel Deaconess Medical Center in Boston, talks about the importance of screening patients with primary biliary...
About 25% of patients with one...
10/21/2020
Gastroenterology
News
Still Disease, Anxiety, and Depression: What’s the Connection?
12/25/2020
The researchers investigated mood status and health-related quality of life among patients with adult-onset Still disease. Here is what they found.
The researchers investigated mood status and health-related quality of life among patients with adult-onset Still disease. Here is what they found.
The researchers investigated...
12/25/2020
Autoimmune
News
Smoking and Psoriasis Risk: What Is the Connection?
10/30/2020
Researchers examined the impact of cigarette smoking on the prevalence and incidence of psoriasis and psoriatic arthritis. Here is what they found.
Researchers examined the impact of cigarette smoking on the prevalence and incidence of psoriasis and psoriatic arthritis. Here is what they found.
Researchers examined the impact...
10/30/2020
Autoimmune
Pop Quiz
Pop Quiz: Ankylosing Spondylitis and IBD
09/16/2020
Do you know whether ankylosing spondylitis affects patients with Crohn disease more often than those with ulcerative colitis, or vice versa? Find out by taking our pop quiz!
Do you know whether ankylosing spondylitis affects patients with Crohn disease more often than those with ulcerative colitis, or vice versa? Find out by taking our pop quiz!
Do you know whether ankylosing...
09/16/2020
Autoimmune
News
TNF-α Inhibitor Antibodies Negatively Affect Course of Inflammatory Joint Disease
07/31/2020
The presence of drug-induced neutralizing antibodies against tumor necrosis factor-α inhibitors may be a reliable biomarker for assessing treatment efficacy in patients with inflammatory joint diseases, a recent study shows.
The presence of drug-induced neutralizing antibodies against tumor necrosis factor-α inhibitors may be a reliable biomarker for assessing treatment efficacy in patients with inflammatory joint diseases, a recent study shows.
The presence of drug-induced...
07/31/2020
Autoimmune

Stay In the Know

Autoimmune Newsletter

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use